Mutant p53 regulates reversible subtype plasticity in pancreatic cancer
Cellular and Molecular Life Sciences · 2025
DOI: 10.1007/s00018-025-05945-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Life Sciences, 2025. Verfasst von June-Ha Shin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Tumor Suppressor Protein p53, Mutation. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
- Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea. jroe@yonsei.ac.kr.
Zitieren
APA
Shin, J. H., Kim, H. R., & Roe, J. S. (2025). Mutant p53 regulates reversible subtype plasticity in pancreatic cancer. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-025-05945-w
Vancouver
Shin JH, Kim HR, Roe JS. Mutant p53 regulates reversible subtype plasticity in pancreatic cancer. Cellular and Molecular Life Sciences. 2025. doi:10.1007/s00018-025-05945-w
BibTeX
@article{Shin2025,
author = {Shin, June-Ha and Kim, Hwa-Ryeon and Roe, Jae-Seok},
title = {Mutant p53 regulates reversible subtype plasticity in pancreatic cancer},
journal = {Cellular and Molecular Life Sciences},
year = {2025},
doi = {10.1007/s00018-025-05945-w}
}
EUVIMED